Cite
Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
MLA
Zhuo, J. L., et al. “Perindopril Chronically Inhibits Angiotensin-Converting Enzyme in Both the Endothelium and Adventitia of the Internal Mammary Artery in Patients with Ischemic Heart Disease.” Circulation, vol. 96, no. 1, July 1997, pp. 174–82. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9236432&authtype=sso&custid=ns315887.
APA
Zhuo, J. L., Froomes, P., Casley, D., Liu, J. J., Murone, C., Chai, S. Y., Buxton, B., & Mendelsohn, F. A. (1997). Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease. Circulation, 96(1), 174–182.
Chicago
Zhuo, J L, P Froomes, D Casley, J J Liu, C Murone, S Y Chai, B Buxton, and F A Mendelsohn. 1997. “Perindopril Chronically Inhibits Angiotensin-Converting Enzyme in Both the Endothelium and Adventitia of the Internal Mammary Artery in Patients with Ischemic Heart Disease.” Circulation 96 (1): 174–82. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9236432&authtype=sso&custid=ns315887.